肺炎支原体肺炎临床治疗

Clinical treatment of mycoplasma pneumoniae pneumonia

目的探讨肺炎支原体肺炎的临床治疗效果。方法本院儿科住院治疗的肺炎支原体肺炎患儿95例,均经过MP-IgM抗体检查确诊为肺炎支原体肺炎。所有患儿均给予阿奇霉素序贯治疗。结果肺炎支原体肺炎多发生于儿童,临床表现主要为发热以及咳嗽,肺部体征与胸部X线检查结果明显不一致。肺外并发症可以累及全身的多个系统。经过治疗后,所有患儿均痊愈或好转出院,痊愈88例,占92.63%;好转7例,占7.37%。结论阿奇毒素序贯疗法治疗肺炎支原体肺炎,疗效确切,值得临床推广。

Objective To investigate the therapeutic effects of mycoplasma pneumoniae pneumonia. Methods Ninety-five cases of patients with mycoplasma pneumoniae pneumonia diagnosed by MP-IgM antibody test in pediatric department of our hospital were all given azithromycin sequential therapy. Results Mycoplasma pneumoniae pneumonia occurred more in children, the main clinical manifestations were fever and cough, and puhnonary signs were inconsistency with chest X-ray apparent. Extrapnlmonary complications could involve multiple systems of the body. After the treatment, all patients were cured or improved and discharged, 88 cases were cured, accounted for 92.63%; 7 cases were improved, accounted for 7.37%. Conclusion Azithromycin sequential therapy in the treatment of mycoplasma pneumoniae pneumonia is efficacy, and worthy of promotion.